MEDHERANT LIMITED

Active Coventry

Research and experimental development on biotechnology

21 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
M

MEDHERANT LIMITED

Research and experimental development on biotechnology

Founded 2 Apr 2014 Active Coventry, England 21 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 10 Mar 2026 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 8 Apr 2026 Next due 16 Apr 2027 11 months remaining
Net assets £-1M £3M 2025 year on year
Total assets £3M £520K 2025 year on year
Total Liabilities £4M £3M 2025 year on year
Charges 2
2 satisfied

Contact & Details

Contact

Registered Address

The Venture Centre Sir William Lyons Road, University Of Warwick Science Park Coventry CV4 7EZ England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for MEDHERANT LIMITED (08973262), an active life sciences and medical technology company based in Coventry, England. Incorporated 2 Apr 2014. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Net Assets, Total Assets & Total Liabilities (2014–2025)

Cash in Bank

£752.76k

Decreased by £152.27k (-17%)

Net Assets

-£1.41M

Decreased by £3.11M (-183%)

Total Liabilities

£4.20M

Increased by £2.59M (+160%)

Turnover

N/A

Employees

21

Debt Ratio

151%

Increased by 102 (+208%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
2024
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 7
Grants 1

Investors (4)

Investor NameInvestor SinceParticipating Rounds
Investor 3Mar 2015Seed
Investor 4Mar 2015Seed
Investor 1Dec 2017Unknown/Other

Share Capital

Share Capital

Share allotments and capital structure

19 Allotments 59,075 Shares £11.56m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
13 Oct 2025328£3.28£3.28
30 Jun 20251,852£500k£270
31 Mar 20251,852£500k£270
31 Mar 20257,836£1.59m£202.5
20 Feb 20251,440£14.4£0.01

Officers

Officers

1 active 2 resigned
Status
Crawford, Francesca Elizabeth, DrDirectorBritishUnited Kingdom741 Jul 2023Active

Shareholders

Shareholders (63)

James Robson
71.7%
242,496
Mercia (general Partner) Ltd, As General Partner Of Mercia Investment Plan Lp
7.3%
24,819

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Group Structure

Group Structure

MEDHERANT LIMITED Current Company

Charges

Charges

2 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
8 Apr 2026Confirmation StatementConfirmation statement made on 2 Apr 2026 with updates
10 Mar 2026AccountsAnnual accounts made up to 31 Dec 2025
3 Dec 2025AccountsAnnual accounts made up to 31 Mar 2026
29 Oct 2025CapitalAllotment of shares (GBP 744.01) on 13 Oct 2025
30 Sept 2025OfficersTermination of James Richard Robson as director on 30 Sept 2025
8 Apr 2026 Confirmation Statement

Confirmation statement made on 2 Apr 2026 with updates

10 Mar 2026 Accounts

Annual accounts made up to 31 Dec 2025

3 Dec 2025 Accounts

Annual accounts made up to 31 Mar 2026

29 Oct 2025 Capital

Allotment of shares (GBP 744.01) on 13 Oct 2025

30 Sept 2025 Officers

Termination of James Richard Robson as director on 30 Sept 2025

Recent Activity

Latest Activity

Confirmation statement made on 2 Apr 2026 with updates

1 months ago on 8 Apr 2026

Annual accounts made up to 31 Dec 2025

2 months ago on 10 Mar 2026

Annual accounts made up to 31 Mar 2026

5 months ago on 3 Dec 2025

Allotment of shares (GBP 744.01) on 13 Oct 2025

6 months ago on 29 Oct 2025

Termination of James Richard Robson as director on 30 Sept 2025

7 months ago on 30 Sept 2025